Protalix Biotherapeutics, Inc. (PLX)
2.17
+0.01
(+0.46%)
USD |
NYAM |
Mar 26, 15:00
Protalix Biotherapeutics Free Cash Flow : -13.63M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Denali Therapeutics, Inc. | -422.10M |
| Agenus, Inc. | -77.20M |
| Lisata Therapeutics, Inc. | -15.98M |
| InspireMD, Inc. | -36.76M |
| Lifeward Ltd. | -16.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.03M |
| Cash from Investing (Quarterly) | -1.112M |
| Cash from Financing (Quarterly) | 0.146M |
| Free Cash Flow Per Share (Quarterly) | 0.0202 |
| Free Cash Flow to Equity (Quarterly) | 1.483M |
| Free Cash Flow to Firm (Quarterly) | 2.068M |
| Free Cash Flow Yield | -7.87% |